Iradimed (IRMD) Non-Current Deferred Tax Liability (2013 - 2023)
Iradimed's (IRMD) quarterly Non-Current Deferred Tax Liability came in at $1.1 million in Q4 2023, up 78.48% on a QoQ basis from $611269.0 in Q4 2018.
Iradimed (IRMD) Non-Current Deferred Tax Liability (2013 - 2023) Analysis & Trends
Iradimed (IRMD) has 5 years of Non-Current Deferred Tax Liability data on file, last reported at $1.1 million in Q4 2023.
- On a quarterly basis, Non-Current Deferred Tax Liability changed N/A year-over-year to $1.1 million in Q4 2023; TTM through Dec 2023 was $1.1 million, a N/A change from a year earlier, with the FY2023 full-year figure at $1.1 million, changed N/A from the prior year.
- Non-Current Deferred Tax Liability for Q4 2023 stood at $1.1 million, up from $611269.0 in the prior quarter.
- Over the last five years, Non-Current Deferred Tax Liability for IRMD reached as high as $1.1 million in Q4 2023 and fell as low as $1.1 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Iradimed | 1.20 Bn | 1.14 Bn | 16.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 1.09 Mn |
| Dec 31, 2023 | 1.09 Mn |
| Dec 31, 2018 | 611,269.00 |
| Dec 31, 2018 | 611,269.00 |
| Dec 31, 2017 | 615,186.00 |
| Dec 31, 2017 | 615,186.00 |
| Dec 31, 2016 | 660,636.00 |
| Dec 31, 2016 | 660,636.00 |
| Dec 31, 2013 | 54,087.00 |
| Dec 31, 2013 | 54,087.00 |